Loading rounds…
Loading rounds…
Explore funding rounds, the companies behind them and the investors taking part.
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| P PharmaceleraCompany profile Applies Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery Applies Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery | €6M | Growth | Biotech | Spain | Investors | |
| SB Sift BiosciencesCompany profile Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases |
Ranked by rounds participated in · All time
AusperBio, Abcuro, Infinimmune
Epicrispr Biotechnologies, Draig Therapeutics, Triveni Bio
LifeMine Therapeutics, Ollin Biosciences, SonoThera
Leal Therapeutics, Khartis Therapeutics, Vedana Therapeutics
Leal Therapeutics, Amplifica Holdings Group, InduPro
Explore published rounds while the next edition is being prepared.
Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases
| $3.7M |
| Pre-SeedPre-seed |
| Biotech |
| United States |
| Investors |
| BT Develops precision immune therapies for glioblastoma | €2.5M | StrategicUndisclosed | Biotech | Sweden | Investors |
| SL Seek LabsCompany profile Develops a programmable disease response platform to detect protect and counter disease threats Develops a programmable disease response platform to detect protect and counter disease threats | $2M | GrantUndisclosed | Biotech | United States | Investors |
| G GelMEDIXCompany profile Develops regenerative therapies to restore vision by regenerating damaged retinal cells Develops regenerative therapies to restore vision by regenerating damaged retinal cells | $13M | Seed | Biotech | United States | Investors |
| B Provides AI-powered platform for bioprocess development and optimization | Undisclosed | StrategicUndisclosed | Biotech | United States | Investors |
| OM OncoRes MedicalCompany profile Develops a hand-held real-time intraoperative imaging device to improve the detection of residual cancer during surgery Develops a hand-held real-time intraoperative imaging device to improve the detection of residual cancer during surgery | $27M | Growth | Biotech, Healthtech | Australia | Investors |
| TB The Biological ComputingCompany profile Integrates living neurons with AI for more efficient computing Integrates living neurons with AI for more efficient computing | $25M | Seed | Biotech, Healthtech | United States | Investors |
| L Developing lifespan extension drugs for dogs | $100M | Series CSeries C+ | Biotech | United States | Investors |
| AO Atlas Oncology PartnersCompany profile Delivers uplifting and responsive cancer care during and beyond treatment Delivers uplifting and responsive cancer care during and beyond treatment | $28M | Series A | Biotech, Healthtech | United States | Investors |